The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included approximately 800 elderly men with low testosterone and symptoms associated with this illness, including testosterone therapy side effects - click through the next website page, sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
Research has shown that testosterone deficiency is associated with several critical health issues for example diabetes, obesity, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should get therapy. In fact, your testosterone levels have probably been slowly decreasing for quite some time, a decline that generally starts around age 30.
No clear lower limit of testosterone was established; yet 15 ng per dL (0.5 nmol per L) generally is used. One study 38 found that girls with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all scenarios and absent or markedly decreased climaxes. Due to studies in this way, supplemented with anecdotal evidence, many girls are started on testosterone treatment. Most girls can expect to spend one third of their lives in the postmenopausal period. Depression, rage, moodiness, insomnia, and lack of well-being are common complaints of postmenopausal women.